Search Results - "Forstpointner R"

Safety and Efficacy of Mosunetuzumab: Experience in the Hospital Cardinale Giovanni Panico.

Authors: Turco, Giulio Tarantino, Donatella Ferraro, Antonietta Giuseppa et al.

Source: Antibodies (2073-4468). Jun2026, Vol. 15 Issue 3, p40. 17p.

Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss.

Authors: Gaumond, Simonetta I. Shrestha, Sophie Kamholtz, Isabella et al.

Source: Cancers. Mar2026, Vol. 18 Issue 5, p861. 18p.

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.

Authors: Bastos-Oreiro, Mariana Gutierrez, Antonio Cabero, Almudena et al.

Source: Cancers. Apr2024, Vol. 16 Issue 7, p1285. 12p.

A randomized phase II study comparing consolidation with a single dose of ⁹⁰Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

Authors: López-Guillermo, Armando Canales, Miguel Ángel Dlouhy, Ivan et al.

Source: Leukemia & Lymphoma. Jan2022, Vol. 63 Issue 1, p93-100. 8p.

Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2025.

Authors: Peñalver, Francisco-Javier Magnano, Laura Alonso-Álvarez, Sara et al.

Source: Cancers. Feb2026, Vol. 18 Issue 3, p395. 25p.

In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab.

Authors: Fadaos N Dor YB Azoulay T et al.

Source: Annals of hematology [Ann Hematol] 2024 Dec; Vol. 103 (12), pp. 5861-5870. Date of Electronic Publication: 2024 Dec 12.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Metastatic embryonal rhabdomyosarcoma of the breast: A case report and literature review.

Authors: Ma, Xuejin Chen, Xiaoxi Jiang, Guoyuan et al.

Source: Breast Journal. Dec2021, Vol. 27 Issue 12, p890-894. 5p.

A Review of Anti-CD20 Antibodies in the Management of B-Cell Lymphomas.

Authors: Mahadevia, Himil Ananthamurugan, Mirdhula Shah, Kashish et al.

Source: Lymphatics. Mar2024, Vol. 2 Issue 1, p10-24. 15p.

Author Index.

Source: Hematological oncology 2025 Supplement; Vol. 43.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0278-0232

Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series.

Authors: Rausch C Schwicht C Doedens D et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Oct; Vol. 174, pp. 37-39. Date of Electronic Publication: 2022 Aug 12.

Publication Type: Letter

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Maintenance regimen of GM‐CSF with rituximab and lenalidomide improves survival in high‐risk B‐cell lymphoma by modulating natural killer cells.

Authors: Sun, Shunrong Fulati, Wulipan Shen, Lin et al.

Source: Cancer Medicine. Jun2023, Vol. 12 Issue 12, p12975-12985. 11p.

Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma.

Authors: Huwyler, Fabrizio Kunz, Rebekka Bacher, Ulrike et al.

Source: Cancers. Apr2023, Vol. 15 Issue 7, p2091. 11p.

Antibody Therapy for Patients with Lymphoid Malignancies: Past and Present.

Authors: Naman, Jacob Shah, Nirja Heyman, Benjamin M.

Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 4, p1711. 21p.

Long-Term Survival of Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-Dose Chemotherapy and Stem Cell Transplantation: A Monocenter Study.

Authors: Kröger, Kai Siats, Jan Kerkhoff, Andrea et al.

Source: Cancers. Feb2023, Vol. 15 Issue 3, p983. 10p.

Pegfilgrastim in Supportive Care of Hodgkin Lymphoma.

Authors: Cerchione, Claudio Nappi, Davide Romano, Alessandra et al.

Source: Cancers. Sep2022, Vol. 14 Issue 17, p4063. 8p.

Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

Authors: Peñalver, Francisco‐Javier Márquez, José‐Antonio Durán, Soledad et al.

Source: Cancer Medicine. Nov2019, Vol. 8 Issue 16, p6955-6966. 12p.

Exosome complex genes mediate RNA degradation and predict survival in mantle cell lymphoma.

Authors: Zhang, Weilong Zhu, Junyong He, Xue et al.

Source: Oncology Letters. Nov2019, Vol. 18 Issue 5, p5119-5128. 10p.

Outcomes of patients with relapsed low-grade lymphoma retreated with rituximab are similar to rituximab naïve patients.

Authors: Vijenthira, Abi Maganti, Manjula Kukreti, Vishal et al.

Source: Leukemia & Lymphoma. Oct2019, Vol. 60 Issue 10, p2576-2579. 4p.

Diagnosis and management of follicular lymphoma: A comprehensive review.

Authors: Dada, Reyad^1,2 (AUTHOR) rdada@kfshrc.edu.sa

Source: European Journal of Haematology. Sep2019, Vol. 103 Issue 3, p152-163. 12p.

Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma.

Authors: Nagai, Hirokazu Shimomura, Takeshi Takeuchi, Makoto et al.

Source: Leukemia & Lymphoma. Dec2017, Vol. 58 Issue 12, p2845-2851. 7p. 2 Diagrams, 3 Charts, 2 Graphs.